Market Place
Sourcing Support
Cellusion Receives U.S. FDA Orphan Drug Designation for CLS001
22 Dec 2023 //
BUSINESSWIRE
Cellusion Announces First Patient Transplanted iPSC-Derived CLS001
27 Mar 2023 //
BUSINESSWIRE
Cellusion, Minaris Enter LOI for Manufacturing Process for Cell Therapy
12 Oct 2022 //
CONTRACTPHARMA
Cellusion and Minaris Regenerative Medicine, a Member of Showa Denko Materials
05 Oct 2022 //
PHARMIWEB
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.